AIMC Topic: Dihydropyrimidine Dehydrogenase Deficiency

Clear Filters Showing 1 to 1 of 1 articles

An Application of Machine Learning in Pharmacovigilance: Estimating Likely Patient Genotype From Phenotypical Manifestations of Fluoropyrimidine Toxicity.

Clinical pharmacology and therapeutics
Dihydropyrimidine dehydrogenase (DPD)-deficient patients might only become aware of their genotype after exposure to dihydropyrimidines, if testing is performed. Case reports to pharmacovigilance databases might only contain phenotypical manifestatio...